Private Banking
|
Professional Solutions
|
Investment Management
|
Investment Banking
|
About us
EN
Contact
Login
Van Lanschot Kempen Logo
Solutions
Sectors
Careers
Van Lanschot Kempen Logo
Login
Home
Investment Banking
Corporate Finance
Transactions
2013
Galapagos April
Apr 2013
Joint Bookrunner
€ 53.9 million
Accelerated Bookbuild Offering
Galapagos
Galapagos is a Belgian biotech company listed on Euronext Brussels and Euronext Amsterdam
Galapagos placed 2,696,831 shares (10% of outstanding shares) in the accelerated bookbuild offering
Participating investors were mainly located in the US, and predominantly included specialist healthcare investors
Kempen acted as Joint Bookrunner, combining supply and demand in order not to put unnecessary pressure on the share price